ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act By Ogkologos - June 11, 2025 536 0 Facebook Twitter Google+ Pinterest WhatsApp Ensuring equitable access to cancer treatments remains central to EU health security efforts Source RELATED ARTICLESMORE FROM AUTHOR The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights of Patients with Cancer via Cross-Border Best Practices and Collaboration Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer ESMO Welcomes Launch of Health Package Introducing EU Measures That Can Boost Innovation in Oncology and Help Prevent New Cancer Cases MOST POPULAR Breast Cancer Patient Devotes Her Time to Driving Others to Treatment March 15, 2021 ΚΑΡΚΙΝΟΣ ΗΠΑΤΟΣ December 10, 2018 The UK Government’s spending review: Time to invest in the future... October 20, 2020 Cancer in My Community: Developing Pediatric Palliative and Supportive Care in... January 16, 2024 Load more HOT NEWS Metformin May Affect Risk of Breast Cancer in Women with Type... FDA Approves Pembrolizumab for Advanced MSI-H/dMMR Endometrial Carcinoma New Blood Test Can Screen For Over 50 Cancers Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Prolongs OS Among...
